Profile data is unavailable for this security.
About the company
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.
- Revenue in CAD (TTM)30.21m
- Net income in CAD30.95m
- Incorporated2004
- Employees6.00
- LocationCipher Pharmaceuticals Inc5750 Explorer Drive,, Suite 404MISSISSAUGA L4W 0A9CanadaCAN
- Phone+1 (905) 602-5840
- Fax+1 (905) 602-5840
- Websitehttps://www.cipherpharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncolytics Biotech Inc | 0.00 | -28.21m | 112.38m | 29.00 | -- | 4.89 | -- | -- | -0.4027 | -0.4027 | 0.00 | 0.3046 | 0.00 | -- | -- | -- | -80.51 | -81.99 | -88.84 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0468 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
| Spectral Medical Inc | 1.74m | -17.93m | 134.31m | 29.00 | -- | -- | -- | 77.37 | -0.0643 | -0.0647 | 0.0062 | -0.0721 | 0.2507 | 3.23 | 2.19 | 59,862.07 | -258.89 | -109.65 | -18,581.35 | -175.35 | 37.85 | 63.74 | -1,032.89 | -445.72 | 0.3287 | -2.56 | -- | -- | -4.14 | -16.08 | -104.12 | -- | 31.53 | -- |
| Eupraxia Pharmaceuticals Inc | 0.00 | -41.75m | 136.56m | 29.00 | -- | 5.12 | -- | -- | -1.65 | -1.65 | 0.00 | 0.7486 | 0.00 | -- | -- | 0.00 | -122.29 | -127.84 | -185.74 | -935.99 | -- | -- | -- | -- | -- | -85.63 | 0.3455 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
| NervGen Pharma Corp | 0.00 | -20.02m | 139.99m | 10.00 | -- | 7.43 | -- | -- | -0.3363 | -0.3363 | 0.00 | 0.2692 | 0.00 | -- | -- | -- | -78.68 | -121.15 | -138.24 | -180.20 | -- | -- | -- | -- | -- | -9.07 | 0.0092 | -- | -- | -- | -8.01 | -- | 2.20 | -- |
| Zentek Ltd | 33.61k | -11.98m | 153.39m | 27.00 | -- | 6.82 | -- | 4,563.88 | -0.1197 | -0.1197 | 0.0003 | 0.2228 | 0.0013 | 0.0796 | 0.0876 | 1,244.82 | -44.53 | -41.94 | -48.53 | -44.46 | -573.70 | -- | -35,636.60 | -12,771.31 | 4.27 | -- | 0.0538 | -- | -79.01 | -- | 54.52 | -- | 39.27 | -- |
| Medicenna Therapeutics Corp | 0.00 | -15.42m | 172.16m | 18.00 | -- | 8.60 | -- | -- | -0.2215 | -0.2215 | 0.00 | 0.2675 | 0.00 | -- | -- | -- | -50.19 | -48.65 | -56.66 | -54.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 55.49 | -- | -- | -- |
| Cipher Pharmaceuticals Inc | 30.21m | 30.95m | 215.72m | 6.00 | 7.33 | 1.85 | 6.63 | 7.14 | 1.22 | 1.22 | 1.19 | 4.84 | 0.2613 | 1.61 | 3.18 | -- | 26.76 | 21.53 | 29.60 | 27.40 | 81.27 | 83.58 | 102.43 | 57.31 | 7.55 | -- | 0.0038 | 0.00 | 2.36 | -1.44 | -23.48 | 76.18 | -53.51 | -- |
| Cardiol Therapeutics Inc | 0.00 | -30.22m | 218.32m | 17.00 | -- | 10.86 | -- | -- | -0.4622 | -0.4622 | 0.00 | 0.2938 | 0.00 | -- | -- | -- | -72.11 | -58.97 | -91.89 | -68.62 | -- | -- | -- | -158,738.10 | -- | -- | 0.0083 | -- | -- | -- | 9.06 | -- | 36.06 | -- |
| OrganiGram Holdings Inc | 152.91m | -289.27m | 249.99m | 987.00 | -- | 0.8411 | -- | 1.63 | -3.57 | -3.57 | 1.80 | 2.88 | 0.3461 | 2.11 | 5.44 | 163,538.00 | -65.48 | -23.49 | -72.67 | -25.39 | -18.34 | -6.87 | -189.18 | -97.37 | 1.98 | -13.02 | 0.0004 | -- | 10.86 | 67.04 | -1,640.54 | -- | -11.62 | -- |
